1. |
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2018, 68(6): 394-424.
|
2. |
Li J, Zhang BN, Fan JH, et al. A nation-wide multicenter 10-year (1999-2008) retrospective clinical epidemiological study of female breast cancer in China. BMC Cancer, 2011, 11: 364.
|
3. |
Fan L, Strasser-Weippl K, Li JJ, et al. Breast cancer in China. Lancet Oncol, 2014, 15(7): e279-e289.
|
4. |
Ruiterkamp J, Ernst MF, de Munck L, et al. Improved survival of patients with primary distant metastatic breast cancer in the period of 1995-2008. A nationwide population-based study in the Netherlands. Breast Cancer Res Treat, 2011, 128(2): 495-503.
|
5. |
Shien T, Nakamura K, Shibata T, et al. A randomized controlled trial comparing primary tumour resection plus systemic therapy with systemic therapy alone in metastatic breast cancer (PRIM-BC): Japan Clinical Oncology Group Study JCOG1017. Jpn J Clin Oncol, 2012, 42(10): 970-973.
|
6. |
Miller JW, Smith JL, Ryerson AB, et al. Disparities in breast cancer survival in the United States (2001-2009): findings from the CONCORD-2 study. Cancer, 2017, 123(Suppl 24): 5100-5118.
|
7. |
Xiong Z, Deng G, Huang X, et al. Score for the survival probability in metastasis breast cancer: a nomogram-based risk assessment model. Cancer Res Treat, 2018, 50(4): 1260-1269.
|
8. |
Danna EA, Sinha P, Gilbert M, et al. Surgical removal of primary tumor reverses tumor-induced immunosuppression despite the presence of metastatic disease. Cancer Res, 2004, 64(6): 2205-2211.
|
9. |
Norton L, Massagué J. Is cancer a disease of self-seeding? Nat Med, 2006, 12(8): 875-878.
|
10. |
Folkman J. New perspectives in clinical oncology from angiogenesis research. Eur J Cancer, 1996, 32A(14): 2534-2539.
|
11. |
Cady B, Nathan NR, Michaelson JS, et al. Matched pair analyses of stage Ⅳ breast cancer with or without resection of primary breast site. Ann Surg Oncol, 2008, 15(12): 3384-3395.
|
12. |
Rapiti E, Verkooijen HM, Vlastos G, et al. Complete excision of primary breast tumor improves survival of patients with metastatic breast cancer at diagnosis. J Clin Oncol, 2006, 24(18): 2743-2749.
|
13. |
Babiera GV, Rao R, Feng L, et al. Effect of primary tumor extirpation in breast cancer patients who present with stage Ⅳ disease and an intact primary tumor. Ann Surg Oncol, 2006, 13(6): 776-782.
|
14. |
Fields RC, Jeffe DB, Trinkaus K, et al. Surgical resection of the primary tumor is associated with increased long-term survival in patients with stage Ⅳ breast cancer after controlling for site of metastasis. Ann Surg Oncol, 2007, 14(12): 3345-3351.
|
15. |
McGuire KP, Eisen S, Rodriguez A, et al. Factors associated with improved outcome after surgery in metastatic breast cancer patients. Am J Surg, 2009, 198(4): 511-515.
|
16. |
Shien T, Kinoshita T, Shimizu C, et al. Primary tumor resection improves the survival of younger patients with metastatic breast cancer. Oncol Rep, 2009, 21(3): 827-832.
|
17. |
Ruiterkamp J, Ernst MF, van de Poll-Franse LV, et al. Surgical resection of the primary tumour is associated with improved survival in patients with distant metastatic breast cancer at diagnosis. Eur J Surg Oncol, 2009, 35(11): 1146-1151.
|
18. |
Neuman HB, Morrogh M, Gonen M, et al. Stage Ⅳ breast cancer in the era of targeted therapy: does surgery of the primary tumor matter? Cancer, 2010, 116(5): 1226-1233.
|
19. |
Nguyen DH, Truong PT, Alexander C, et al. Can locoregional treatment of the primary tumor improve outcomes for women with stage Ⅳ breast cancer at diagnosis? Int J Radiat Oncol Biol Phys, 2012, 84(1): 39-45.
|
20. |
Nguyen DH, Truong PT, Walter CV, et al. Limited M1 disease: a significant prognostic factor for stage Ⅳ breast cancer. Ann Surg Oncol, 2012, 19(9): 3028-3034.
|
21. |
Rashaan ZM, Bastiaannet E, Portielje JE, et al. Surgery in metastatic breast cancer: patients with a favorable profile seem to have the most benefit from surgery. Eur J Surg Oncol, 2012, 38(1): 52-56.
|
22. |
Thomas A, Khan SA, Chrischilles EA, et al. Initial surgery and survival in stage Ⅳ breast cancer in the United States, 1988-2011. JAMA Surg, 2016, 151(5): 424-431.
|
23. |
Blanchard DK, Shetty PB, Hilsenbeck SG, et al. Association of surgery with improved survival in stage Ⅳ breast cancer patients. Ann Surg, 2008, 247(5): 732-738.
|
24. |
Harano K, Lei X, Gonzalez-Angulo AM, et al. Clinicopathological and surgical factors associated with long-term survival in patients with HER2-positive metastatic breast cancer. Breast Cancer Res Treat, 2016, 159(2): 367-374.
|
25. |
Wong Y, Raghavendra AS, Hatzis C, et al. Long-term survival of de novo stage Ⅳ human epidermal growth receptor 2 (HER2) positive breast cancers treated with HER2-targeted therapy. Oncologist, 2019, 24(3): 313-318.
|
26. |
AlJohani B, AlMalik O, Anwar E, et al. Impact of surgery on survival in stage Ⅳ breast cancer. Breast J, 2016, 22(6): 678-682.
|
27. |
Kim HJ, Kang E, Kim JH, et al. Survival benefit of surgical removal of primary tumor in patients with stage Ⅳ breast cancer. Clin Breast Cancer, 2018, 18(5): e1037-e1044.
|
28. |
Badwe R, Hawaldar R, Nair N, et al. Locoregional treatment versus no treatment of the primary tumour in metastatic breast cancer: an open-label randomised controlled trial. Lancet Oncol, 2015, 16(13): 1380-1388.
|
29. |
King TA, Lyman JP, Gonen M, et al. A prospective analysis of surgery and survival in stage Ⅳ breast cancer (TBCRC 013). J Clin Oncol, 2016, 34(15): 1006.
|
30. |
Fitzal F, Bjelic-Radisic V, Knauer M, et al. Impact of breast surgery in primary metastasized breast cancer: outcomes of the prospective randomized phase Ⅲ ABCSG-28 POSYTIVE trial. Ann Surg, 2019, 269(6): 1163-1169.
|
31. |
Soran A, Ozmen V, Ozbas S, et al. Randomized trial comparing resection of primary tumor with no surgery in stage Ⅳ breast cancer at presentation: protocol MF07-01. Ann Surg Oncol, 2018, 25(11): 3141-3149.
|
32. |
Petrelli F, Barni S. Surgery of primary tumors in stage Ⅳ breast cancer: an updated meta-analysis of published studies with meta-regression. Med Oncol, 2012, 29(5): 3282-3290.
|
33. |
Harris E, Barry M, Kell MR. Meta-analysis to determine if surgical resection of the primary tumour in the setting of stage Ⅳ breast cancer impacts on survival. Ann Surg Oncol, 2013, 20(9): 2828-2834.
|
34. |
Lu S, Wu J, Fang Y, et al. The impact of surgical excision of the primary tumor in stage Ⅳ breast cancer on survival: a meta-analysis. Oncotarget, 2017, 9(14): 11816-11823.
|
35. |
Ruiterkamp J, Voogd AC, Tjan-Heijnen VC, et al. SUBMIT: systemic therapy with or without up front surgery of the primary tumor in breast cancer patients with distant metastases at initial presentation. BMC Surg, 2012, 12: 5.
|
36. |
National Cancer Institute. Early surgery or standard palliative therapy in treating patients with stage Ⅳ breast cancer. https: //www.cancer.gov/about-cancer/treatment/clinical-trials/search/v?id=NCT01242800&r=1.
|
37. |
Xie Y, Lv X, Luo C, et al. Surgery of the primary tumor improves survival in women with stage Ⅳ breast cancer in Southwest China: a retrospective analysis. Medicine (Baltimore), 2017, 96(22): e7048.
|
38. |
Wang W, Liu J, Wang J, et al. Impact of locoregional treatment on prognosis of de novo stage Ⅳ breast cancer: a retrospective long-term study of Chinese population. Gynecol Obstet Invest, 2019, 84(3): 248-258.
|
39. |
Xiong Z, Deng G, Wang J, et al. Could local surgery improve survival in de novo stage Ⅳ breast cancer? BMC Cancer, 2018, 18(1): 885.
|
40. |
Co M, Ng J, Kwong A. De-novo metastatic breast cancers with or without primary tumor resection-a 10-year study. Cancer Treat Res Commun, 2019, 19: 100118.
|
41. |
Han MR, Zheng W, Cai Q, et al. Evaluating genetic variants associated with breast cancer risk in high and moderate-penetrance genes in Asians. Carcinogenesis, 2017, 38(5): 511-518.
|
42. |
Pons-Tostivint E, Kirova Y, Lusque A, et al. Survival impact of locoregional treatment of the primary tumor in de novo metastatic breast cancers in a large multicentric cohort study: a propensity score-matched analysis. Ann Surg Oncol, 2019, 26(2): 356-365.
|
43. |
Peng Z, Wei J, Lu X, et al. Diagnosis and treatment pattern among rural and urban breast cancer patients in Southwest China from 2005 to 2009. Oncotarget, 2016, 7(47): 78168-78179.
|
44. |
Jackisch C, Leinweber M, Küchenmeister U, et al. Psychosocial acceptance of surgical interventions of the breast in oncological gynecology. Zentralbl Gynakol, 1997, 119(5): 218-224.
|